ARTICLE | Company News
BresaGen, Pepgen deal
August 8, 2005 7:00 AM UTC
BGN's protEcol Services business unit will further develop an E. coli-based process to produce Pepgen's Neoferon interferon alpha analog and produce GLP recombinant protein. The process was developed ...